Tonix Pharmaceuticals
Price & Volume
Stats
See more52W Range | $0.11-$12.48 |
Market Cap | $71.5M |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $12.4M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $2.6M |
Diluted EPS | -$80.39 |
News
See moreYahoo Finance • 12 months ago
Tonix Pharmaceuticals Announces Conditional Acceptance of Tonmya™ as Trade Name for TNX-102 SL for the Management of Fibromyalgia
Yahoo Finance • last year
Tonix Pharmaceuticals announces key topline data from 2nd Phase 3 Clinical Trial of TNX-102 SL
Yahoo Finance • last year
Tonix Pharmaceuticals to Present at Two Upcoming Investor Conferences in December
About
CEO | Dr. Seth Lederman M.D. |
CFO | Mr. Bradley Saenger CPA |
Address | 26 Main Street, Chatham, NJ, United States, 07928 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 103 |
